This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Patrick D. Lyden: Innovator in Vascular Injury Research
Introduction
Patrick D. Lyden is a prominent inventor based in San Diego, California. He has made significant contributions to the field of vascular injury research through his innovative patent. His work focuses on utilizing ultrashort laser pulses to induce controlled vascular damage in animal models, which has important implications for medical research and treatment.
Latest Patents
Patrick D. Lyden holds a patent titled "Device and method for inducing vascular injury and/or blockage in an animal model." This invention employs ultrashort laser pulses to create photodisruptive breakdowns in blood vessels, allowing for the controlled production of hemorrhage, thrombosis, or breaches of the blood-brain barrier. The method ensures that damage is limited to the targeted vessels, preserving the integrity of neighboring blood vessels. Additionally, lower energy laser pulses are utilized to observe and quantify blood flow dynamics, providing a real-time, in vivo model for studying vascular injury.
Career Highlights
Patrick D. Lyden is affiliated with the University of California, where he continues to advance his research in vascular injury and treatment methodologies. His innovative approach has garnered attention in the scientific community, contributing to a deeper understanding of vascular dynamics.
Collaborations
He has collaborated with notable colleagues, including Nozomi Nishimura and Christopher B. Schaffer, who share his commitment to advancing research in this critical area of medicine.
Conclusion
Patrick D. Lyden's work exemplifies the intersection of innovation and medical research, particularly in the field of vascular injury. His contributions through patented technology are paving the way for future advancements in understanding and treating vascular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
